Friday, April 30, 2021 • 2:00 PM - 5:00 PM (EST)

Sponsored by ASIP and the Società Italiana di Patologia e Medicina Traslazionale/Italian Society of Pathology and Translational Medicine (SIPMeT) Co-Sponsored by the ASIP Gene Regulation Scientific Interest Group

Session Description: In this session, we will explore the role of epigenetic regulation in cancer development and therapy. The talks will include new and innovative methodologies, molecular studies, and novel targets for treatment.

	Chair - Welcome and Introductions
2:00 PM - 2:45 PM	Targeting Epigenome for Cancer Treatment and Prevention Lucia Altucci, MD, PhD • University of Naples, Naples Italy
2:45 PM - 3:30 PM	Molecular Mechanisms of Epigenetic (Mis)Regulation Tatiana Kutateladze, PhD • University of Colorado
3:30 PM - 4:15 PM	Expanding the Toolbox for Characterizing Epigenetic Protein-Protein Interactions Mediated by Post-translational Modification Marcey Waters, PhD • University of North Carolina at Chapel Hill
4:15 PM - 5:00 PM	Epigenetic regulation and TKI resistance in EGFR-mutant lung cancer: A new role of SMARCA4 Fernando J. de Miguel, PhD • Yale Cancer Center
	Questions and Answers